Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
Head Neck. 2018 Nov;40(11):2514-2520. doi: 10.1002/hed.25390. Epub 2018 Oct 11.
The purpose of this study is to evaluate the prognostic significance of nodes with extracapsular spread (ECS) in patients treated with a planned neck dissection after chemoradiotherapy.
We carried out a retrospective study of 109 cN+ patients who achieved a complete response in the primary location after chemoradiotherapy and treated with a planned neck dissection.
The 5-year disease-specific survival for patients without residual metastatic nodes in the neck dissection (pN0, n = 69) was 75.7% (95% CI: 64.4%-87.0%). For patients with metastatic nodes without ECS (pN+/ECS-negative, n = 17), the corresponding figure was 74.0% (95% CI: 48.2%-99.8%), and for patients with metastatic neck nodes with ECS (pN+/ECS-positive, n = 23) it was 8.7% (95% CI: 0.0%-24.3%) (P = .0001).
The presence of ECS in the pathologic study of the planned neck dissections carried out after chemoradiotherapy in patients with human papillomavirus-negative (HPV-negative) head and neck squamous cell carcinoma (SCC) allows identification of a group of patients with a high risk of failure.
本研究旨在评估接受放化疗后计划行颈清扫术的患者中,颈部淋巴结包膜外扩散(ECS)的淋巴结对预后的影响。
我们对 109 例经放化疗后原发灶完全缓解且行计划颈清扫术的 cN+患者进行了回顾性研究。
颈清扫术未发现残留转移性淋巴结(pN0,n=69)的患者 5 年疾病特异性生存率为 75.7%(95%CI:64.4%-87.0%)。无 ECS 的转移性淋巴结(pN+/ECS-,n=17)的相应生存率为 74.0%(95%CI:48.2%-99.8%),而有 ECS 的转移性颈部淋巴结(pN+/ECS+,n=23)的生存率为 8.7%(95%CI:0.0%-24.3%)(P=0.0001)。
HPV 阴性头颈部鳞状细胞癌(SCC)患者接受放化疗后,计划行颈清扫术的病理研究中存在 ECS 可识别出一组复发风险较高的患者。